# River BioMedics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/river-biomedics-b-v

- Industry: Biotechnology
- Headquarters: Enschede, Netherlands
- Website: www.riverbiomedics.com
- Total disclosed funding: $4.2M
- Latest round: Seed (Jul 5, 2023)
- Investors on record: 4

## About

Founded in 2020 and based in Enschede, Netherlands, River BioMedics B.V. operates as a biotechnology company that creates in vitro 3D heart models for future drug discovery. In July 2023, River BioMedics B.V., raised EUR 2 million in seed funding from investor Libertatis Ergo Holding B.V., with participation from returning investors First Fund, KIKK Capital, and Oost NL. As of 2023, the company is led by its CEO, Nicky Cooper.

The company offers medical technologies and solutions that include advanced diagnostic tools, therapeutic devices, and medical equipment designed to enhance precision, efficiency, and effectiveness in various medical procedures and treatments. The company’s products and services cater to a diverse range of medical specialties, including cardiology, oncology, neurology, and more.

The company plans to use the July 2023 funding to support the development of its product offerings.

## Funding rounds

- Seed, Jul 5, 2023, $2.2M — Oost NL, Libertatis Ergo Holding B.V., KIKK Capital, First Fund
- Seed, Jan 20, 2022, $2M — Oost NL, KIKK Capital, First Fund

## Investors

- Oost NL (https://capitalatlas.ai/funds/oost-nl) — Seed
- KIKK Capital (https://capitalatlas.ai/funds/kikk-capital) — Seed
- First Fund — Seed
- Libertatis Ergo Holding B.V. — Seed